Last update 10 Jan 2025
Biomay AG

Biomay AG

Private Company|
1984|
Austria
|
www.biomay.com

Overview

Tags

Immune System Diseases
Allergen extract

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Allergen extract1

Related

1
Drugs associated with Biomay AG
Recombinant Timothy grass pollen allergoids(Biomay AG)
Target-
Mechanism
Immunomodulators
Active Org.
Biomay AGBiomay AG [+1]
Originator Org.
Biomay AGBiomay AG
Active Indication
Rhinitis, Allergic
Inactive Indication
Anaphylaxis [+3]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
6
Clinical Trials associated with Biomay AG
NCT04912076 / CompletedPhase 1IIT
A Randomized, DBPC Study to Determine the Safety, Tolerability and Immunological Effects of BM41 Compared to Placebo and to Treatment With Standard s.c. Immunotherapy in Patients Allergic to Birch Pollen
EUCTR2015-004551-43-AT / Not yet recruitingPhase 2
Study to evaluate the effect of different pre-seasonal BM32 dosing schedules on the induction of a protective allergen-specific IgG Immune response
NCT02643641 / CompletedPhase 2
Study to Evaluate the Effect of Different Pre-seasonal BM32 Dosing Schedules on the Rapid Induction of a Protective IgG Immune Response
100 Clinical Results associated with Biomay AG
Login to view more data
0 Patents (Medical) associated with Biomay AG
Login to view more data
100 Deals associated with Biomay AG
Login to view more data
100 Translational Medicine associated with Biomay AG
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
4
Other
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free